Published in Gastroenterol Clin Biol on August 23, 2002
Restrictive model of compensated carbon tetrachloride-induced cirrhosis in rats. World J Gastroenterol (2008) 0.79
Brief communication: the relationship of regression of cirrhosis to outcome in chronic hepatitis C. Ann Intern Med (2008) 3.54
Controlling tumor growth by modulating endogenous production of reactive oxygen species. Cancer Res (2005) 3.12
Is liver resection justified for patients with hepatic metastases from breast cancer? Ann Surg (2006) 2.49
Cholecystocolonic fistula: facts and myths. A review of the 231 published cases. J Hepatobiliary Pancreat Surg (2008) 2.40
Recommendations for laparoscopic liver resection: a report from the second international consensus conference held in Morioka. Ann Surg (2015) 2.36
Laparoscopic living donor hepatectomy for liver transplantation in children. Lancet (2002) 2.15
Liver transplantation for neuroendocrine tumors in Europe-results and trends in patient selection: a 213-case European liver transplant registry study. Ann Surg (2013) 1.98
Early survival and safety of ALPPS: first report of the International ALPPS Registry. Ann Surg (2014) 1.69
Mangafodipir prevents liver injury induced by acetaminophen in the mouse. J Hepatol (2003) 1.67
Treatment of stage IVA hepatocellular carcinoma: should we reappraise the role of surgery? Arch Surg (2008) 1.58
Dual role of CCR2 in the constitution and the resolution of liver fibrosis in mice. Am J Pathol (2009) 1.49
Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis. Histopathology (2010) 1.48
Removable intraductal stenting in duct-to-duct biliary reconstruction in liver transplantation. Transpl Int (2011) 1.42
Preliminary report of major surgery in liver transplant recipients receiving m-TOR inhibitors without therapeutic discontinuation. World J Surg (2014) 1.42
Split liver transplantation using extended right grafts: the natural history of segment 4 and its impact on early postoperative outcomes. Liver Transpl (2012) 1.40
Patients with acute liver failure listed for superurgent liver transplantation in France: reevaluation of the Clichy-Villejuif criteria. Liver Transpl (2015) 1.38
European experience of laparoscopic major hepatectomy. J Hepatobiliary Pancreat Sci (2013) 1.33
In situ lipidomic analysis of nonalcoholic fatty liver by cluster TOF-SIMS imaging. Anal Chem (2009) 1.29
Sinusoidal endothelial cell and hepatocyte death following cold ischemia-warm reperfusion of the rat liver. Hepatology (2004) 1.26
Hepatic resection after rescue cetuximab treatment for colorectal liver metastases previously refractory to conventional systemic therapy. J Clin Oncol (2007) 1.23
International experience for laparoscopic major liver resection. J Hepatobiliary Pancreat Sci (2014) 1.23
Pivotal role of superoxide anion and beneficial effect of antioxidant molecules in murine steatohepatitis. Hepatology (2004) 1.21
Hepatitis C: epidemiology, diagnosis, natural history and therapy. Contrib Nephrol (2012) 1.20
Mitogenic insulin receptor-A is overexpressed in human hepatocellular carcinoma due to EGFR-mediated dysregulation of RNA splicing factors. Cancer Res (2013) 1.17
Bone marrow transplantation in mice leads to a minor population of hepatocytes that can be selectively amplified in vivo. Hepatology (2002) 1.17
Recurrent liver abscess secondary to ingested fish bone migration: report of a case. Surg Today (2008) 1.13
Conditional cell ablation by tight control of caspase-3 dimerization in transgenic mice. Nat Biotechnol (2002) 1.11
Major liver resection without clamping: a prospective reappraisal in the era of modern surgical tools. J Am Coll Surg (2004) 1.04
Temporary placement of partially covered self-expandable metal stents for anastomotic biliary strictures after liver transplantation: a prospective, multicenter study. Gastrointest Endosc (2010) 1.04
HIP/PAP accelerates liver regeneration and protects against acetaminophen injury in mice. Hepatology (2005) 1.03
Cetuximab plus gemcitabine-oxaliplatin (GEMOX) in patients with refractory advanced intrahepatic cholangiocarcinomas. Oncology (2007) 1.01
Interleukin-4 induces the activation and collagen production of cultured human intrahepatic fibroblasts via the STAT-6 pathway. Lab Invest (2008) 1.00
Pure laparoscopic left lateral sectionectomy in living donors: from innovation to development in France. Ann Surg (2015) 0.99
A new indication for liver transplantation: nodular regenerative hyperplasia in human immunodeficiency virus-infected patients. Liver Transpl (2008) 0.99
High levels of catalytic antibodies correlate with favorable outcome in sepsis. Proc Natl Acad Sci U S A (2005) 0.99
Mature hepatocytes are the source of small hepatocyte-like progenitor cells in the retrorsine model of liver injury. J Hepatol (2004) 0.99
Pancreatic fistula after pancreaticoduodenectomy: the conservative treatment of choice. HPB (Oxford) (2009) 0.99
Apoptosis of human hepatic myofibroblasts promotes activation of matrix metalloproteinase-2. Hepatology (2002) 0.98
E-cadherin/p120-catenin and tetraspanin Co-029 cooperate for cell motility control in human colon carcinoma. Cancer Res (2010) 0.97
Laparoscopy Decreases Pulmonary Complications in Patients Undergoing Major Liver Resection: A Propensity Score Analysis. Ann Surg (2016) 0.97
Combined hepatocellular-cholangiocarcinomas exhibit progenitor features and activation of Wnt and TGFβ signaling pathways. Carcinogenesis (2012) 0.95
Geographic disparities in access to organ transplant in France. Transplantation (2003) 0.95
Liver transplantation for hepatopulmonary syndrome: a ten-year experience in Paris, France. Transplantation (2003) 0.93
Assessment of epidermal growth factor receptor (EGFR) expression in primary colorectal carcinomas and their related metastases on tissue sections and tissue microarray. Virchows Arch (2006) 0.93
Improving anti-hepatitis C virus therapy. Expert Opin Biol Ther (2006) 0.93
Thoracoscopic removal of mediastinal parathyroid glands: a critical appraisal of an emerging technique. Ann Surg (2010) 0.92
Long-term outcome of pediatric liver transplantation for biliary atresia: a 10-year follow-up in a single center. Liver Transpl (2005) 0.91
A novel, sensitive, and specific RT-PCR technique for quantitation of hepatitis C virus replication. J Med Virol (2007) 0.91
Protection against hepatocyte mitochondrial dysfunction delays fibrosis progression in mice. Am J Pathol (2009) 0.90
Transient micro-elastography: A novel non-invasive approach to measure liver stiffness in mice. World J Gastroenterol (2011) 0.90
Functional results after laparoscopic Heller myotomy for achalasia: A comparative study to open surgery. Surgery (2004) 0.90
The combination of ischemic preconditioning and liver Bcl-2 overexpression is a suitable strategy to prevent liver and lung damage after hepatic ischemia-reperfusion. Am J Pathol (2002) 0.88
Is there an immunohistochemical technique definitively valid in epidermal growth factor receptor assessment? Oncol Rep (2006) 0.88
Hepatocellular carcinoma developed on compensated cirrhosis: resection as a selection tool for liver transplantation. Liver Transpl (2008) 0.88
MDR1 gene expression in hepatocellular carcinoma and the peritumoral liver of patients with and without cirrhosis. Cancer Lett (2002) 0.88
Liver disease in adult patients with cystic fibrosis: a frequent and independent prognostic factor associated with death or lung transplantation. J Hepatol (2011) 0.88
Chemical imaging on liver steatosis using synchrotron infrared and ToF-SIMS microspectroscopies. PLoS One (2009) 0.87
GH receptor plays a major role in liver regeneration through the control of EGFR and ERK1/2 activation. Endocrinology (2011) 0.86
In vivo cell lineage analysis during chemical hepatocarcinogenesis in rats using retroviral-mediated gene transfer: evidence for dedifferentiation of mature hepatocytes. Lab Invest (2002) 0.86
Congenital portosystemic shunts in children: a new anatomical classification correlated with surgical strategy. Ann Surg (2014) 0.86
Long-term outcomes following aggressive management of recurrent hepatocellular carcinoma after upfront liver resection. World J Surg (2012) 0.85
Laparoscopic division of a portosystemic shunt to treat chronic hepatic encephalopathy. HPB (Oxford) (2008) 0.85
Interleukin-4 induces human hepatocyte apoptosis through a Fas-independent pathway. FASEB J (2007) 0.85
Lessons learned from the first 100 laparoscopic liver resections: not delaying conversion may allow reduced blood loss and operative time. J Laparoendosc Adv Surg Tech A (2012) 0.85
Increased susceptibility to liver fibrosis with age is correlated with an altered inflammatory response. Rejuvenation Res (2011) 0.84
EGFR: A Master Piece in G1/S Phase Transition of Liver Regeneration. Int J Hepatol (2012) 0.84
Delayed liver regeneration in mice lacking liver serum response factor. Am J Physiol Gastrointest Liver Physiol (2006) 0.83
Mycoplasma hominis infection in renal transplantation. Nephrol Dial Transplant (2002) 0.83
Vessel identifications tags for open or laparoscopic associating liver partition and portal vein ligation for staged hepatectomy. J Am Coll Surg (2013) 0.83
Interest of preoperative immunonutrition in liver resection for cancer: study protocol of the PROPILS trial, a multicenter randomized controlled phase IV trial. BMC Cancer (2014) 0.82
Adjuvant interleukin-12 gene therapy for the management of colorectal liver metastases. Cancer Gene Ther (2004) 0.82
Mesenchymal stem cells: an alternative source of hepatocytes? Hepatology (2004) 0.81
[National health and nutrition program: challenges of a global action plan]. Rev Prat (2009) 0.81
Loss of epidermal growth factor receptor expression in lymph node and liver metastases of colon carcinoma. J Clin Oncol (2005) 0.81
[IL28 (interferon lambda3) gene polymorphisms and response to IFN-alpha treatment in patients infected with hepatitis virus C]. Med Sci (Paris) (2010) 0.81
[Conservative management of esophageal perforation after pneumatic dilatation for achalasia]. Gastroenterol Clin Biol (2002) 0.81
[Humanized mice for the study of hepatitis C]. Med Sci (Paris) (2011) 0.81
Interleukin-15 production during liver allograft rejection in humans. Transplantation (2003) 0.81
Outcome of orthotopic liver transplantation in autoimmune hepatitis according to subtypes. Transpl Int (2002) 0.81
Elevated interleukin-4 expression in severe recurrent hepatitis C virus after liver transplantation. Transplantation (2007) 0.80
CD25, CD28 and CD38 expression in peripheral blood lymphocytes as a tool to predict acute rejection after liver transplantation. Clin Transplant (2008) 0.80
Defective inhibition of peripheral CD8+ T cell IL-2 production by anti-calcineurin drugs during acute liver allograft rejection. Transplantation (2004) 0.80
No hepatic iron overload 12 years after liver transplantation for hereditary hemochromatosis. Hepatology (2004) 0.80
Liver repopulation by Bcl-x(L) transgenic hepatocytes. Am J Pathol (2002) 0.80
Efficacy and safety of Celsior preservation fluid in liver transplantation: one-year follow up of a prospective, multicenter, non-randomized study. Clin Transplant (2011) 0.80
Liver repopulation trial using bone marrow cells in a retrorsine-induced chronic hepatocellular injury model. Gastroenterol Clin Biol (2006) 0.80
Pancreatic mucinous cystadenoma in an adult with cystic fibrosis. Clin Res Hepatol Gastroenterol (2011) 0.79
Overexpression of Bcl-2 in hepatocytes protects against injury but does not attenuate fibrosis in a mouse model of chronic cholestatic liver disease. Lab Invest (2010) 0.79
Might physicians be restricting access to liver transplantation for patients with alcoholic liver disease? J Hepatol (2009) 0.79
Impaired erythropoietin production in liver transplant recipients: the role of calcineurin inhibitors. Liver Transpl (2006) 0.79
Restrictive model of compensated carbon tetrachloride-induced cirrhosis in rats. World J Gastroenterol (2008) 0.79
Mobilizing stem cells to repair liver after surgery: dream or reality? J Hepatol (2005) 0.79